The mechanisms whereby IGF-1 alleviates diabetic cardiomyopathy suggested by previous studies include activation of the phosphoinositide 3-kinase/Akt pathway, which prevents apoptosis of cardiomyocytes43, the dissociation of intercalated discs44, mitochondrial dysfunction45 and fragmentation46. Here, AKT1 is linked to diabetic cardiomyopathy.